Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responsesJeppe F. Severens, Erik B. van den Akker, Bert A. van der Reijden et al.|Leukemia|2024Cited by 30